Skip to main content
Back to News
Funding
1 min read
US

OpenAI led a 250 million dollar seed round for Merge Labs at an 850 million dollar valuation to pion...

The AMW Read

The article updates the player map for biological/neurotech AI and introduces a major strategic investment from a top-tier frontier lab (OpenAI), signaling a shift toward biological integration.
NoveltySignificance
Healthcare & Bio Β· Player Map

OpenAI led a 250 million dollar seed round for Merge Labs at an 850 million dollar valuation to pioneer non-invasive brain-computer interfaces. πŸš€ By combining ultrasound with molecular engineering, the startup aims to achieve high-bandwidth neural syncing without the surgical risks of implants. 🧠 This signals a systemic shift toward biological AI integration, addressing the fundamental data-transfer bottleneck between humans and machines. The fusion of foundation models with cellular-level neural data marks the next frontier of human cognitive scaling. 🌐

#AI #Neurotech #OpenAI #BCI #Innovation

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1w agoAdaptyv raises €34.35M Series A for automated protein-design labAdaptyv
  2. 2w agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  3. 2w agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  4. 7mo agoOpenAI led a 250 million dollar seed round for Merge Labs at an 850 million dollar valuation to pion... Β· THIS ARTICLE

Related News

More news from Merge Labs

Stay updated with the latest news and announcements from Merge Labs.

View all Merge Labs news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard